TY  - BOOK
AU  - Taplin,Ruth
AU  - Fuchikawa,Kazuhiko
TI  - Competition Law, Regulation, and Digital Platforms: Japan, China, UK, EU, and USA 
T2  - Routledge studies in the growth economies of Asia 
SN  - 9781032788548
U1  - 343.07/21 23
PY  - 2025///
CY  - Abingdon, Oxon, New York, NY
PB  - Routledge, Taylor & Francis Group
KW  - Antitrust law
KW  - Japan
KW  - China
KW  - Great Britain
KW  - European Union countries
KW  - United States
KW  - Electronic commerce
KW  - Law and legislation
KW  - European Union countries.
N1  - Includes bibliographical references and index.; Overview -- Regulating non-price exclusionary conduct and preferential treatments in the digital economy -- Fair competition and appropriate use of data and algorithms in the digital platforms business-case studies and policy approaches in Japan -- Cloud computing and competition law -- Regulating and competition: A study on competition regulation among digital platforms in China -- Addendum: Excessive patenting in Big Pharma: Should this strategy be regulated by competition law as big tech targets healthcare? -- Conclusion
N2  -  "This book confronts and analyses how competition law in its present form is unable to deal with the new advances in digital technology that have made tech giants not subject to national jurisdictions as they straddle the world, with a particular focus on Japan, China, UK, EU and USA. Demonstrating how the gatekeeping role of digital platforms has broken through the boundaries of national regulation, this book highlights examples where companies have broken and infringed antitrust law with impunity, pursuing self-preferencing/ unfair competition practice for solely their own profitability. It also identifies how tech giants can open their digital platforms for fair use by consumers, SMEs and creators while still allowing tech giants to maintain their important role as gatekeepers of digital security that protects users from cyberattacks. This is followed by an examination of the similarities between tech giants and big pharma within the competition law and intellectual property context, revealing how tech giants are beginning to target the healthcare sector. Exploring how intellectual property rights are interwoven through new modernising regulations to curtail the dominance of Big Tech on digital platforms, this book will appeal to students, scholars and practitioners of Business Ethics, Intellectual Property, Law and Regulation"--Provided by publisher.
ER  -